The current role of systemic chemotherapy in the primary treatment of head and neck cancer
Highlights • Interpreting studies including ICT in HNSCC is complicated by several protocols, treatment settings and different endpoints. • ICT has a role in selected HNSCC patients with high risk for distant metastasis. • ICT is beneficial for selected patients, who can conduct the complex and toxi...
Gespeichert in:
| Veröffentlicht in: | Cancer treatment reviews 2015-03, Vol.41 (3), p.217-221 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 221 |
|---|---|
| container_issue | 3 |
| container_start_page | 217 |
| container_title | Cancer treatment reviews |
| container_volume | 41 |
| creator | Busch, C.-J Tribius, S Schafhausen, P Knecht, R |
| description | Highlights • Interpreting studies including ICT in HNSCC is complicated by several protocols, treatment settings and different endpoints. • ICT has a role in selected HNSCC patients with high risk for distant metastasis. • ICT is beneficial for selected patients, who can conduct the complex and toxic treatment schedule. |
| doi_str_mv | 10.1016/j.ctrv.2015.02.002 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1672603032</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0305737215000237</els_id><sourcerecordid>1672603032</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-4abc00f0f1a4202b3312e2d2276008202bf6a53e69fa3b653d5cc09bb11023113</originalsourceid><addsrcrecordid>eNp9kU1r3DAQhkVJabZp_0APRcdc7I5Ga2kNJRBCvyDQQ9NLL0KWx6w2_thKcmD_fWR2k0MOOWkQ7_PCPMPYJwGlAKG-7EqXwkOJIKoSsATAN2wlKomFqJU-YyuQUBVaajxn72PcAUAtVf2OnWOlNrre4Ir9u9sSd3MINCYepp741PF4iIkG77jb0jClLQW7P3A_8jzyffCDDQeeAtk0LFgmtmRbbseWj-TuubOjo_CBve1sH-nj6b1gf79_u7v5Wdz-_vHr5vq2cGutU7G2jQPooBN2jYCNlAIJW0StADbLT6dsJUnVnZWNqmRbOQd10wgBKIWQF-zy2LsP0_-ZYjKDj4763o40zdEIpVFlFRJzFI9RF6YYA3XmtI0RYBanZmcWp2ZxagBNdpqhz6f-uRmofUaeJObA12OA8pYPnoKJzlNW0PpALpl28q_3X73AXe9H72x_TweKu2kOY_ZnhIkZMH-Wqy5HFRUsuJaPSVicRQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1672603032</pqid></control><display><type>article</type><title>The current role of systemic chemotherapy in the primary treatment of head and neck cancer</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Busch, C.-J ; Tribius, S ; Schafhausen, P ; Knecht, R</creator><creatorcontrib>Busch, C.-J ; Tribius, S ; Schafhausen, P ; Knecht, R</creatorcontrib><description>Highlights • Interpreting studies including ICT in HNSCC is complicated by several protocols, treatment settings and different endpoints. • ICT has a role in selected HNSCC patients with high risk for distant metastasis. • ICT is beneficial for selected patients, who can conduct the complex and toxic treatment schedule.</description><identifier>ISSN: 0305-7372</identifier><identifier>EISSN: 1532-1967</identifier><identifier>DOI: 10.1016/j.ctrv.2015.02.002</identifier><identifier>PMID: 25687982</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Carcinoma, Squamous Cell - drug therapy ; Carcinoma, Squamous Cell - radiotherapy ; Chemoradiotherapy ; Concurrent radiochemotherapy ; Head and neck cancer ; Head and Neck Neoplasms - drug therapy ; Head and Neck Neoplasms - radiotherapy ; Hematology, Oncology and Palliative Medicine ; Humans ; Induction chemotherapy ; Organ preservation ; Randomized Controlled Trials as Topic ; Squamous Cell Carcinoma of Head and Neck</subject><ispartof>Cancer treatment reviews, 2015-03, Vol.41 (3), p.217-221</ispartof><rights>Elsevier Ltd</rights><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-4abc00f0f1a4202b3312e2d2276008202bf6a53e69fa3b653d5cc09bb11023113</citedby><cites>FETCH-LOGICAL-c477t-4abc00f0f1a4202b3312e2d2276008202bf6a53e69fa3b653d5cc09bb11023113</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0305737215000237$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25687982$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Busch, C.-J</creatorcontrib><creatorcontrib>Tribius, S</creatorcontrib><creatorcontrib>Schafhausen, P</creatorcontrib><creatorcontrib>Knecht, R</creatorcontrib><title>The current role of systemic chemotherapy in the primary treatment of head and neck cancer</title><title>Cancer treatment reviews</title><addtitle>Cancer Treat Rev</addtitle><description>Highlights • Interpreting studies including ICT in HNSCC is complicated by several protocols, treatment settings and different endpoints. • ICT has a role in selected HNSCC patients with high risk for distant metastasis. • ICT is beneficial for selected patients, who can conduct the complex and toxic treatment schedule.</description><subject>Carcinoma, Squamous Cell - drug therapy</subject><subject>Carcinoma, Squamous Cell - radiotherapy</subject><subject>Chemoradiotherapy</subject><subject>Concurrent radiochemotherapy</subject><subject>Head and neck cancer</subject><subject>Head and Neck Neoplasms - drug therapy</subject><subject>Head and Neck Neoplasms - radiotherapy</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Induction chemotherapy</subject><subject>Organ preservation</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Squamous Cell Carcinoma of Head and Neck</subject><issn>0305-7372</issn><issn>1532-1967</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1r3DAQhkVJabZp_0APRcdc7I5Ga2kNJRBCvyDQQ9NLL0KWx6w2_thKcmD_fWR2k0MOOWkQ7_PCPMPYJwGlAKG-7EqXwkOJIKoSsATAN2wlKomFqJU-YyuQUBVaajxn72PcAUAtVf2OnWOlNrre4Ir9u9sSd3MINCYepp741PF4iIkG77jb0jClLQW7P3A_8jzyffCDDQeeAtk0LFgmtmRbbseWj-TuubOjo_CBve1sH-nj6b1gf79_u7v5Wdz-_vHr5vq2cGutU7G2jQPooBN2jYCNlAIJW0StADbLT6dsJUnVnZWNqmRbOQd10wgBKIWQF-zy2LsP0_-ZYjKDj4763o40zdEIpVFlFRJzFI9RF6YYA3XmtI0RYBanZmcWp2ZxagBNdpqhz6f-uRmofUaeJObA12OA8pYPnoKJzlNW0PpALpl28q_3X73AXe9H72x_TweKu2kOY_ZnhIkZMH-Wqy5HFRUsuJaPSVicRQ</recordid><startdate>20150301</startdate><enddate>20150301</enddate><creator>Busch, C.-J</creator><creator>Tribius, S</creator><creator>Schafhausen, P</creator><creator>Knecht, R</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150301</creationdate><title>The current role of systemic chemotherapy in the primary treatment of head and neck cancer</title><author>Busch, C.-J ; Tribius, S ; Schafhausen, P ; Knecht, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-4abc00f0f1a4202b3312e2d2276008202bf6a53e69fa3b653d5cc09bb11023113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Carcinoma, Squamous Cell - drug therapy</topic><topic>Carcinoma, Squamous Cell - radiotherapy</topic><topic>Chemoradiotherapy</topic><topic>Concurrent radiochemotherapy</topic><topic>Head and neck cancer</topic><topic>Head and Neck Neoplasms - drug therapy</topic><topic>Head and Neck Neoplasms - radiotherapy</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Induction chemotherapy</topic><topic>Organ preservation</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Squamous Cell Carcinoma of Head and Neck</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Busch, C.-J</creatorcontrib><creatorcontrib>Tribius, S</creatorcontrib><creatorcontrib>Schafhausen, P</creatorcontrib><creatorcontrib>Knecht, R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer treatment reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Busch, C.-J</au><au>Tribius, S</au><au>Schafhausen, P</au><au>Knecht, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The current role of systemic chemotherapy in the primary treatment of head and neck cancer</atitle><jtitle>Cancer treatment reviews</jtitle><addtitle>Cancer Treat Rev</addtitle><date>2015-03-01</date><risdate>2015</risdate><volume>41</volume><issue>3</issue><spage>217</spage><epage>221</epage><pages>217-221</pages><issn>0305-7372</issn><eissn>1532-1967</eissn><abstract>Highlights • Interpreting studies including ICT in HNSCC is complicated by several protocols, treatment settings and different endpoints. • ICT has a role in selected HNSCC patients with high risk for distant metastasis. • ICT is beneficial for selected patients, who can conduct the complex and toxic treatment schedule.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>25687982</pmid><doi>10.1016/j.ctrv.2015.02.002</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0305-7372 |
| ispartof | Cancer treatment reviews, 2015-03, Vol.41 (3), p.217-221 |
| issn | 0305-7372 1532-1967 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1672603032 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - radiotherapy Chemoradiotherapy Concurrent radiochemotherapy Head and neck cancer Head and Neck Neoplasms - drug therapy Head and Neck Neoplasms - radiotherapy Hematology, Oncology and Palliative Medicine Humans Induction chemotherapy Organ preservation Randomized Controlled Trials as Topic Squamous Cell Carcinoma of Head and Neck |
| title | The current role of systemic chemotherapy in the primary treatment of head and neck cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T18%3A34%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20current%20role%20of%20systemic%20chemotherapy%20in%20the%20primary%20treatment%20of%20head%20and%20neck%20cancer&rft.jtitle=Cancer%20treatment%20reviews&rft.au=Busch,%20C.-J&rft.date=2015-03-01&rft.volume=41&rft.issue=3&rft.spage=217&rft.epage=221&rft.pages=217-221&rft.issn=0305-7372&rft.eissn=1532-1967&rft_id=info:doi/10.1016/j.ctrv.2015.02.002&rft_dat=%3Cproquest_cross%3E1672603032%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1672603032&rft_id=info:pmid/25687982&rft_els_id=1_s2_0_S0305737215000237&rfr_iscdi=true |